Chargement en cours...

Treatment of hepatitis C virus infection in the future

Two direct-acting antivirals (DAAs) against hepatitis C virus (HCV): telaprevir and boceprevir, are now available in combination with peginterferon plus ribavirin for the treatment of chronic hepatitis C infection. Although these drugs are potent inhibitors of HCV replication, they occasionally resu...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kanda, Tatsuo, Yokosuka, Osamu, Omata, Masao
Format: Artigo
Langue:Inglês
Publié: Springer 2013
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637513/
https://ncbi.nlm.nih.gov/pubmed/23577631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2001-1326-2-9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!